• Je něco špatně v tomto záznamu ?

Geometric Ring Annuloplasty for Aortic Valve Repair During Aortic Aneurysm Surgery: Two-Year Clinical Trial Results

JS. Rankin, D. Mazzitelli, T. Fischlein, YH. Choi, J. Pirk, S. Pfeiffer, LM. Wei, V. Badhwar,

. 2018 ; 13 (4) : 248-253.

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc19000432

OBJECTIVE: An aortic annuloplasty ring could be useful for aortic valve repair. This trial evaluated intermediate-term outcomes of internal geometric ring annuloplasty for repair of trileaflet and bicuspid aortic insufficiency associated with ascending aortic and/or aortic root aneurysms. METHODS: Under regulatory supervision, 47 patients with aortic insufficiency and ascending aortic (n = 22) and/or aortic root (n = 25) aneurysms were managed with aortic valve repair and aneurysm resection. Valve repair was performed using trileaflet (n = 40) or bicuspid (n = 7) internal geometric rings, together with leaflet reconstruction. Ascending aortic and/or remodeling root replacements were accomplished with Dacron grafts 5 to 7 mm larger than the rings. An Echo Core Lab provided independent echocardiographic assessments, and changes over time were evaluated by Friedman tests. RESULTS: Mean ± SD age was 60 ± 14 years, 57% (27/47) were male, 15% (7/47) had bicuspid valves, 87% (41/47) had moderate-to-severe aortic insufficiency, and 13% (6/47) had mild aortic insufficiency. All patients had annular dilatation, with a mean ± SD of 26.5 ± 2.6 mm before repair, and mean ± SD ring sizes were 21.7 ± 1.7 mm. Follow-up was 42 months (mean = 27 months). No operative mortality or valve-related complications occurred. Two patients died beyond 1 year from nonvalve-related causes. One patient required valve replacement for repair failure. Survival free of complications or valve replacement was 94% at 2 years. Significant reduction in aortic insufficiency and New York Heart Association class were observed (P < 0.0001), and valve gradients remained low. No heart block or direct ring complications occurred. CONCLUSIONS: In preliminary regulatory studies, aortic ring annuloplasty seemed safe and effective during aortic aneurysm surgery. This approach could help standardize aortic valve repair.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19000432
003      
CZ-PrNML
005      
20190121102844.0
007      
ta
008      
190107s2018 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1097/IMI.0000000000000539 $2 doi
035    __
$a (PubMed)30138245
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Rankin, J Scott
245    10
$a Geometric Ring Annuloplasty for Aortic Valve Repair During Aortic Aneurysm Surgery: Two-Year Clinical Trial Results / $c JS. Rankin, D. Mazzitelli, T. Fischlein, YH. Choi, J. Pirk, S. Pfeiffer, LM. Wei, V. Badhwar,
520    9_
$a OBJECTIVE: An aortic annuloplasty ring could be useful for aortic valve repair. This trial evaluated intermediate-term outcomes of internal geometric ring annuloplasty for repair of trileaflet and bicuspid aortic insufficiency associated with ascending aortic and/or aortic root aneurysms. METHODS: Under regulatory supervision, 47 patients with aortic insufficiency and ascending aortic (n = 22) and/or aortic root (n = 25) aneurysms were managed with aortic valve repair and aneurysm resection. Valve repair was performed using trileaflet (n = 40) or bicuspid (n = 7) internal geometric rings, together with leaflet reconstruction. Ascending aortic and/or remodeling root replacements were accomplished with Dacron grafts 5 to 7 mm larger than the rings. An Echo Core Lab provided independent echocardiographic assessments, and changes over time were evaluated by Friedman tests. RESULTS: Mean ± SD age was 60 ± 14 years, 57% (27/47) were male, 15% (7/47) had bicuspid valves, 87% (41/47) had moderate-to-severe aortic insufficiency, and 13% (6/47) had mild aortic insufficiency. All patients had annular dilatation, with a mean ± SD of 26.5 ± 2.6 mm before repair, and mean ± SD ring sizes were 21.7 ± 1.7 mm. Follow-up was 42 months (mean = 27 months). No operative mortality or valve-related complications occurred. Two patients died beyond 1 year from nonvalve-related causes. One patient required valve replacement for repair failure. Survival free of complications or valve replacement was 94% at 2 years. Significant reduction in aortic insufficiency and New York Heart Association class were observed (P < 0.0001), and valve gradients remained low. No heart block or direct ring complications occurred. CONCLUSIONS: In preliminary regulatory studies, aortic ring annuloplasty seemed safe and effective during aortic aneurysm surgery. This approach could help standardize aortic valve repair.
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a aortální aneurysma $x mortalita $x chirurgie $7 D001014
650    _2
$a aortální chlopeň $x chirurgie $7 D001021
650    12
$a anuloplastika srdeční chlopně $x škodlivé účinky $x přístrojové vybavení $x mortalita $x statistika a číselné údaje $7 D058385
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a srdeční chlopně umělé $x škodlivé účinky $7 D006350
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a pooperační komplikace $7 D011183
650    _2
$a protézy - design $7 D011474
650    _2
$a reoperace $7 D012086
655    _2
$a časopisecké články $7 D016428
700    1_
$a Mazzitelli, Domenico $u Department of Cardiac Surgery, Klinikum Bogenhausen, Munich, Germany.
700    1_
$a Fischlein, Theodor $u Department of Cardiovascular Surgery, Klinikum Nürnberg, Paracelsus Medical University, Nürnberg, Germany.
700    1_
$a Choi, Yeong-Hoon $u Department of Cardiac and Thoracic Surgery, University of Köln, Köln, Germany.
700    1_
$a Pirk, Jan $u Department of Cardiac Surgery, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
700    1_
$a Pfeiffer, Steffen $u Department of Cardiovascular Surgery, Klinikum Nürnberg, Paracelsus Medical University, Nürnberg, Germany.
700    1_
$a Wei, Lawrence M
700    1_
$a Badhwar, Vinay
773    0_
$w MED00181718 $t Innovations (Philadelphia, Pa.) $x 1559-0879 $g Roč. 13, č. 4 (2018), s. 248-253
856    41
$u https://pubmed.ncbi.nlm.nih.gov/30138245 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20190107 $b ABA008
991    __
$a 20190121103102 $b ABA008
999    __
$a ok $b bmc $g 1363843 $s 1038555
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2018 $b 13 $c 4 $d 248-253 $i 1559-0879 $m Innovations $n Innovations (Phila) $x MED00181718
LZP    __
$a Pubmed-20190107

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...